Biofil Chemicals Stock Screener | Share Price & Fundamental Analysis
BIOFILCHEM
Pharmaceuticals
Screen Biofil Chemicals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹34.49
▲
1.00 (2.99%)
Share Price BSE
₹34.71
▲
1.12 (3.33%)
Market Cap
₹54.50 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.52
EPS (TTM)
₹0.34
Dividend Yield
-
Debt to Equity
0.02
52W High
₹44.68
52W Low
₹32.83
Operating Margin
1.00%
Profit Margin
6.52%
Revenue (TTM)
₹46.00
EBITDA
₹4.00
Net Income
₹3.00
Total Assets
₹51.00
Total Equity
₹19.00
Biofil Chemicals Share Price History - Stock Screener Chart
Screen BIOFILCHEM historical share price movements with interactive charts. Analyze price trends and patterns.
Biofil Chemicals Company Profile - Fundamental Screener
Screen Biofil Chemicals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BIOFILCHEM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE829A01014
Biofil Chemicals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen BIOFILCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 51 | 47 | 31 | 19 | 33 | 42 | 24 | 24 | 22 | 24 |
| Current Assets | 43 | 38 | 22 | 9 | 24 | 32 | 14 | 15 | 13 | 15 |
| Fixed Assets | 8 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 | 9 |
| Liabilities | ||||||||||
| Total Liabilities | 51 | 47 | 31 | 19 | 33 | 42 | 24 | 24 | 22 | 24 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 19 | 18 | 17 | 17 | 16 | 15 | 14 | 13 | 13 | 11 |
| Share Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves & Surplus | 3 | 2 | 1 | 1 | 0 | -1 | -3 | -3 | -4 | -5 |
Screen BIOFILCHEM income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46 | 34 | 41 | 30 | 23 | 37 | 30 | 23 | 13 | 14 | 14 | 6 |
| Expenses | 42 | 33 | 39 | 29 | 21 | 34 | 28 | 22 | 11 | 11 | 12 | 5 |
| EBITDA | 4 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 3 | 1 | 1 |
| Operating Profit % | 1.00% | 3.00% | 2.00% | 4.00% | 6.00% | 4.00% | 6.00% | 4.00% | 8.00% | 19.00% | 7.00% | 13.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 1 |
| Tax | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
| Net Profit | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
| EPS | 1.80 | 0.34 | 0.44 | 0.34 | 0.44 | 0.77 | 0.74 | 0.30 | 0.29 | 1.10 | 0.48 | 0.36 |
Biofil Chemicals Cash Flow Screener - Liquidity Fundamentals
Screen BIOFILCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -1 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen BIOFILCHEM shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 46.82% | 46.82% | 46.79% | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 38.31% | 38.18% | 38.23% | 38.03% | 37.27% | 38.02% | 38.18% | 38.13% |
| Other Holding | 14.79% | 14.92% | 14.89% | 15.04% | 15.83% | 15.08% | 14.92% | 14.97% |
| Shareholder Count | 25,914 | 25,685 | 25,196 | 26,581 | 25,480 | 26,422 | 26,114 | 27,475 |
Biofil Chemicals Dividend Screener - Share Yield Analysis
Screen BIOFILCHEM dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Biofil Chemicals Index Membership - Market Screener Classification
Screen BIOFILCHEM by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Biofil Chemicals Market Events Screener - Corporate Actions
Screen BIOFILCHEM market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -3.98% | ||
| Annual General Meeting | NA | 24.86% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 3.78% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -5.23% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 9.61% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -3.12% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -8.65% |
Biofil Chemicals Competitors Screener - Peer Comparison
Screen BIOFILCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
Biofil Chemicals Company Announcements - News Screener
Screen BIOFILCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-31 | Closure of Trading Window | View |
| 2025-12-03 | Receipt Of Fine From BSE Limited. | View |
| 2025-11-26 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Board Meeting Outcome for To Review Consider And Approve The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report | View |
| 2025-11-13 | To Review Consider And Approve The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report. | View |
| 2025-11-07 | Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2025. | View |
| 2025-10-04 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-29 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-29 | Scrutinizer Report With Voting Result | View |
| 2025-09-29 | Scrutinizer Report With Voting Result | View |
| 2025-09-27 | Summary Of Proceedings Of 40Th Annual General Meeting Of The Company Held On Saturday 27Th September 2025 Pursuant To Regulation 30 Read With Para A Of Part A Of Schedule III Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015. | View |
| 2025-09-15 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-09-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-29 | Information Regarding E-Voting For 40Th Annual General Meeting | View |
| 2025-08-29 | Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants | View |
| 2025-08-29 | Reg. 34 (1) Annual Report. | View |
| 2025-08-29 | Submission Of Notice Of Convening 40Th AGM Of The Company. | View |
| 2025-08-23 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |